Cargando…
Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia type. Patients with AF are often administered anticoagulants to reduce the risk of ischemic stroke due to an irregular heartbeat. We evaluated the efficacy and safety of edoxaban versus warfarin in patients with nonvalvula...
Autores principales: | Alsultan, Mohammed M., Alahmari, Abdullah K., Mahmoud, Mansour A., Almalki, Ziyad S., Alzlaiq, Wafa, Alqarni, Faisal, Alsultan, Fahad, Ahmed, Nehad Jaser, Alenazi, Ahmed O., Scharf, Lucas, Guo, Jeff Jianfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687440/ https://www.ncbi.nlm.nih.gov/pubmed/38035002 http://dx.doi.org/10.3389/fphar.2023.1276491 |
Ejemplares similares
-
Prevalence of polypharmacy in heart failure patients: A retrospective cross-sectional study in a tertiary hospital in Saudi Arabia
por: Alsultan, Mohammed M., et al.
Publicado: (2023) -
Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
por: Krejczy, Martin, et al.
Publicado: (2015) -
Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease
por: Fukamachi, Daisuke, et al.
Publicado: (2022) -
Factors Associated with Length of Hospital Stay among COVID-19 Patients in Saudi Arabia: A Retrospective Study during the First Pandemic Wave
por: Alahmari, Abdullah K., et al.
Publicado: (2022) -
Plasma Concentration and Pharmacodynamics of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Acute Heart Failure
por: Nabeta, Takeru, et al.
Publicado: (2021)